-
Dyslipidaemia-An update for the pharmacist:Pharmacists Module 4, 2024
Dyslipidaemia refers to abnormal levels of lipids (fats) in the blood, including cholesterol and triglycerides, and is a significant risk factor for cardiovascular disease (CVD). Dyslipidaemia, whether due to genetic or lifestyle factors, can lead to atherosclerosis and other cardiovascular complications and can increase the risk of having a heart attack or stroke.
The community pharmacist can play an important role by offering cholesterol screening. Finger-prick testing is appropriate for screening to determine where advice on lifestyle intervention is required or where patients require referral to the doctor.
Adherence to prescribed therapy declines over time. The pharmacist, therefore, plays a vital role in ensuring that patients continue with their prescribed lipid-lowering therapy.
For more information about this programme, contact Glynis or Gill at Insight Medicine Information at 011 706 6939 or email: cpdalphapharm@insightmed.co.za
